ArticleCells2022

Targeting mGlu1 Receptors in the Treatment of Motor and Cognitive Dysfunctions in Mice Modeling Type 1 Spinocerebellar Ataxia.

Francesca Liberatore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.